Nivolumab + Anti-LAG-3 Antibody in Metastatic Melanoma - 102164

Spotlight
Video

Nivolumab + Anti-LAG-3 Antibody in Metastatic Melanoma

Loading........
Description: Shailender Bhatia, MD of Seattle Cancer Care Alliance discusses his second presentation, which focused on the use of nivolumab plus an anti-LAG 3 antibody for the treatment of metastatic melanoma at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 9520: Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy
Shared By : AnnualMeeting2017
Posted on : 06/13/17
Added : 1 year ago